TYPHIM VI INJECTION 0.025mg/0.5ml

Product Information

Registration Status: Active

TYPHIM VI INJECTION 0.025mg/0.5ml is approved to be sold in Singapore with effective from 1995-12-16. It is marketed by SANOFI-AVENTIS SINGAPORE PTE LTD, with the registration number of SIN08481P.

This product contains Purified Vi Capsular Polysaccharide Of S.Typhi (Type 2 Strain) 25 micrograms in the form of INJECTION. It is approved for SUBCUTANEOUS, INTRAMUSCULAR use.

This product is manufactured by SANOFI PASTEUR S.A. in FRANCE.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Purified Vi Capsular Polysaccharide Of S.Typhi (Type 2 Strain)

Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank